Yoel Kloog PhD (Professor of Biochemistry) , Adrienne D Cox PhD (Assistant Professor)
{"title":"RAS抑制剂:潜在的癌症治疗药物","authors":"Yoel Kloog PhD (Professor of Biochemistry) , Adrienne D Cox PhD (Assistant Professor)","doi":"10.1016/S1357-4310(00)01789-5","DOIUrl":null,"url":null,"abstract":"<div><p>As RAS oncoproteins play a major role in human malignancy, inhibiting RAS function is a promising approach for developing anticancer therapies. Among these approaches are agents such as farnesyltransferase inhibitors (FTIs) and the nontoxic farnesylcysteine analogue farnesylthiosalicylic acid (FTS) that dislodges all RAS isoforms from the membrane, as well as methods to restore regulation of RAS–GTP levels and to alter the interaction of RAS–GTP with downstream targets.</p></div>","PeriodicalId":79448,"journal":{"name":"Molecular medicine today","volume":"6 10","pages":"Pages 398-402"},"PeriodicalIF":0.0000,"publicationDate":"2000-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1357-4310(00)01789-5","citationCount":"87","resultStr":"{\"title\":\"RAS inhibitors: potential for cancer therapeutics\",\"authors\":\"Yoel Kloog PhD (Professor of Biochemistry) , Adrienne D Cox PhD (Assistant Professor)\",\"doi\":\"10.1016/S1357-4310(00)01789-5\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>As RAS oncoproteins play a major role in human malignancy, inhibiting RAS function is a promising approach for developing anticancer therapies. Among these approaches are agents such as farnesyltransferase inhibitors (FTIs) and the nontoxic farnesylcysteine analogue farnesylthiosalicylic acid (FTS) that dislodges all RAS isoforms from the membrane, as well as methods to restore regulation of RAS–GTP levels and to alter the interaction of RAS–GTP with downstream targets.</p></div>\",\"PeriodicalId\":79448,\"journal\":{\"name\":\"Molecular medicine today\",\"volume\":\"6 10\",\"pages\":\"Pages 398-402\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2000-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/S1357-4310(00)01789-5\",\"citationCount\":\"87\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Molecular medicine today\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1357431000017895\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular medicine today","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1357431000017895","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
As RAS oncoproteins play a major role in human malignancy, inhibiting RAS function is a promising approach for developing anticancer therapies. Among these approaches are agents such as farnesyltransferase inhibitors (FTIs) and the nontoxic farnesylcysteine analogue farnesylthiosalicylic acid (FTS) that dislodges all RAS isoforms from the membrane, as well as methods to restore regulation of RAS–GTP levels and to alter the interaction of RAS–GTP with downstream targets.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
